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A MAP kinase docking site is required for phosphorylation and
activation of p90rsk/MAPKAP kinase-1
Anne-Claude Gavin and Angel R. Nebreda
Activation of the various mitogen-activated protein
(MAP) kinase pathways converts many different
extracellular stimuli into specific cellular responses by
inducing the phosphorylation of particular groups of
substrates. One important determinant for substrate
specificity is likely to be the amino-acid sequence
surrounding the phosphorylation site; however, these
sites overlap significantly between different MAP
kinase family members. The idea is now emerging that
specific docking sites for protein kinases are involved in
the efficient binding and phosphorylation of some
substrates [1–4]. The MAP kinase-activated protein
(MAPKAP) kinase p90rsk contains two kinase domains
[5]: the amino-terminal domain (D1) is required for the
phosphorylation of exogenous substrates whereas the
carboxy-terminal domain (D2) is involved in
autophosphorylation. Association between the
extracellular signal-regulated kinase (Erk) MAP kinases
and p90rsk family members has been detected in various
cell types including Xenopus oocytes [6–8], where
inactive p90rsk is bound to the inactive form of the Erk2-
like MAP kinase p42mpk1. Here, we identify a new MAP
kinase docking site located at the carboxyl terminus of
p90rsk. This docking site was required for the efficient
phosphorylation and activation of p90rsk in vitro and in
vivo and was also both necessary and sufficient for the
stable and specific association with p42mpk1. The
sequence of the docking site was conserved in other
MAPKAP kinases, suggesting that it might represent a
new class of interaction motif that facilitates efficient
and specific signal transduction by MAP kinases.
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Results and discussion
Using a yeast two-hybrid assay, we confirmed that full-
length p90rsk associates with p42mpk1 (see Supplemen-
tary material published with this paper on the internet).
Moreover, the D2 domain of p90rsk (amino acids
309–733) alone, but not the D1 domain (amino acids
1–308) alone, could also associate with p42mpk1. We
tested the specificity of this interaction by using as a bait
the related Xenopus MAP kinase p38mpk2; this MAP
kinase did not interact with either full-length p90rsk or
the D2 domain alone. As a further control, p38mpk2 but
not p42mpk1 interacted with another MAPKAP kinase,
MAPKAP kinase-2. Consistent with these results, we
found that a fusion protein containing glutathione-S-
transferase (GST) fused to the D2 domain (GST–D2),
but not a similar fusion protein containing the D1
domain (GST–D1), was efficiently phosphorylated in
vitro by purified active p42mpk1. In contrast, p38mpk2 was
much less efficient at phosphorylating GST–D2 (see
Supplementary material).
The interaction between the D2 domain of p90rsk and
p42mpk1 was confirmed using bacterially produced GST
fusion proteins bound to glutathione beads for ‘pull-down’
experiments. We found that Myc-tagged p42mpk1 expressed
in Xenopus oocytes bound to GST–D2 but not to either
GST alone or GST–D1 (see Supplementary material). The
association was observed using either control oocytes or
oocytes treated with progesterone to activate p42mpk1, sug-
gesting that GST–D2 can also bind active p42mpk1. This
was confirmed by using antibodies specific for the phospho-
rylated form of p42mpk1, which could detect both Myc-
tagged p42mpk1 and endogenous p42mpk1 in GST–D2
pull-down assays. The phosphorylated full-length form of
p90rsk, however, did not appear to bind efficiently to active
p42mpk1 (data not shown). 
To further characterise the interaction between Xenopus
p90rsk and p42mpk1, we prepared truncated forms of p90rsk
and the D2 domain that lacked the last 43 amino acids
(p90rsk∆43 and D2∆43, respectively). Deletion of this
carboxy-terminal region has been shown to impair associa-
tion between human Rsk3 and the MAP kinase Erk2 [8].
Using the yeast two-hybrid system we found that the
removal of only the last 43 amino acids of p90rsk completely
abrogated the ability of both p90rsk and the D2 domain to
interact with p42mpk1 (Figure 1a). We then investigated
whether these carboxy-terminal 43 amino acids were also
required for the association between D2 and p42mpk1 in
Xenopus oocytes. For this experiment, Myc-tagged D2 and
D2∆43 were expressed in Xenopus oocytes, immunoprecipi-
tated with anti-Myc antibodies and analysed by
immunoblotting using either anti-Myc or anti-p42mpk1 anti-
bodies. Anti-Myc antibodies immunoprecipitated D2 and
D2∆43 with the same efficiency (Figure 1b, upper panel),
but the endogenous p42mpk1 co-immunoprecipitated only
with D2 (Figure 1b, lower panel), confirming that the
removal of the last 43 amino acids completely abrogates the
ability of D2 to interact with p42mpk1. 
We then wanted to determine whether the carboxy-termi-
nal 43 amino acids of p90rsk alone (43Ct) were sufficient
for interaction with p42mpk1. We found that 43Ct either
alone or fused to the carboxyl terminus of MAPKAP
kinase-2 (MAPKAPK-2–43Ct) was able to interact with
p42mpk1 in a yeast two-hybrid assay (Figure 1a). To
confirm these results, Myc-tagged forms of D2, D1,
D1–43Ct, MAPKAP kinase-2 and MAPKAPK-2–43Ct,
were expressed in Xenopus oocytes and analysed for
binding to p42mpk1 as described above. All proteins were
recovered in anti-Myc immunoprecipitates with the same
efficiency (Figure 1c, upper panel). Although p42mpk1 was
detected neither in D1 nor in MAPKAP kinase-2
immunoprecipitates, it did co-immunoprecipitate with
both D1–43Ct and MAPKAPK-2–43Ct, albeit to a lesser
extent than with D2 (Figure 1c, lower panel). These
results demonstrate that the fusion of the 43Ct region to
proteins that normally do not associate with p42mpk1 can
target these proteins to this MAP kinase.
To evaluate the importance of the docking site in the 43Ct
region for efficient phosphorylation by p42mpk1, we incu-
bated different amounts of recombinant GST–D2 and
GST–D2∆43 with active p42mpk1 and [γ-32P]ATP in an in
vitro kinase assay (Figure 2a and Supplementary material).
The deletion of the carboxy-terminal 43 amino acids
reduced the efficiency of D2 phosphorylation by p42mpk1
in vitro by more than 10-fold (Figure 2a, left panel). This
effect was not due to the removal of p42mpk1 phosphory-
lation sites on D2, because GST–43Ct alone was very
poorly phosphorylated by p42mpk1 in vitro (Figure 2a, right
panel), which is consistent with the absence of MAP kinase
phosphorylation sites in 43Ct [9]. We also investigated the
importance of 43Ct for the in vivo phosphory-lation and
activation of p90rsk by p42mpk1. For this experiment we
expressed both p90rsk and p90rsk∆43 in Xenopus oocytes
and then triggered the activation of p42mpk1 by proges-
terone stimulation (Figure 2b). We found that the deletion
of the 43 carboxy-terminal amino acids in p90rsk∆43
severely impaired its ability to be phosphorylated during
oocyte maturation, although both endogenous p90rsk and
endogenous p42mpk1 were phosphorylated to the same
extent in all progesterone-treated samples (Figure 2b, left
panels). Furthermore, when p90rsk∆43 was immunoprecip-
itated from oocyte lysates, it showed a significant inhibi-
tion of both its autophosphorylation activity (Figure 2c,
upper panel) and its ability to phosphorylate exogenous
substrates (Figure 2c, middle and lower panels) when com-
pared with full-length p90rsk. These results suggest that
the 43 carboxy-terminal amino acids are required for the
efficient phosphorylation and activation of p90rsk by
p42mpk1 in Xenopus oocytes. Moreover, GST–43Ct inhib-
ited the phosphorylation of p90rsk by p42mpk1 in vitro
(Figure 2d), further suggesting an important role for the
interaction between the 43Ct docking site and p42mpk1. 
Interestingly, the D1 domain of p90rsk, which is not phos-
phorylated by p42mpk1 either in vitro (see Supplementary
material) or during oocyte maturation (Figure 2b and data
not shown), might become phosphorylated by p42mpk1
when fused to 43Ct as suggested by the upward mobility
shift of the D1–43Ct fusion protein following electrophore-
sis of progesterone-treated oocyte samples (Figure 2b,
middle panels). Similarly, MAPKAP kinase-2 fused to
43Ct but not MAPKAP kinase-2 alone showed reduced
electrophoretic mobility upon expression in oocytes
injected with recombinant Mos protein to activate p42mpk1
(Figure 2b, right panels), suggesting that MAPKAPK-
2–43Ct was more heavily phosphorylated by p42mpk1. Fur-
thermore, although MAPKAP kinase-2 is efficiently
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Figure 1
Identification of a docking site in p90rsk that is necessary and
sufficient for p42mpk1 binding. (a) Interaction in the yeast two-hybrid
assay between p42mpk1 and the indicated proteins. Growth on
selective media after mating is indicated by +. All mating mixtures had
the same rate of growth on non-selective media. (b,c) Interaction in co-
immunoprecipitation (IP) experiments between the Myc-tagged
versions of the indicated proteins expressed in Xenopus oocytes and
endogenous p42mpk1. Lysates prepared from 30 oocytes were
immunoprecipitated with anti-Myc antibody and both the total lysates
and the anti-Myc immunoprecipitates were analysed by immunoblotting
with anti-Myc antibodies (upper panel) and anti-p42mpk1 antibodies
(lower panel), as previously described [17]. 
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activated by p42mpk1 when overexpressed in oocytes, we
could still measure a small but reproducible increase (about
twofold) in the in vitro kinase activity of MAPKAPK-
2–43Ct upon p42mpk1 activation in oocytes. Addition of the
43Ct region to MAPKAP kinase-2, however, did not affect
the activation of this MAPKAP kinase by p38mpk2 in
oocytes (data not shown). These results indicate that 43Ct
can direct p42mpk1-mediated phosphorylation of proteins
other than p90rsk in vivo. To define a shorter sequence for
the MAP kinase docking site in 43Ct, we prepared a trun-
cated form of D2 lacking the last 18 amino acids (D2∆18),
which did not associate with p42mpk1 in the yeast two-
hybrid assay (Figure 3a). We also found that the carboxy-
terminal 25 amino acids of p90rsk (25Ct) alone were able to
interact with p42mpk1 in the yeast two-hybrid assay
(Figure 3a). Furthermore, GST–25Ct was able to pull
down p42mpk1 from oocyte lysates with the same efficiency
as GST–43Ct (Figure 3b) and GST–D2 (data not shown). 
In summary, we have identified an Erk MAP-kinase
docking site at the carboxyl terminus of p90rsk that is 
specific for p42mpk1 binding and is required for the efficient
phosphorylation and activation of p90rsk by p42mpk1 both in
vitro and in vivo. This 25 amino acid sequence contains a
motif that is highly conserved in all the Rsk isoforms iden-
tified so far [10–12], as well as in the Erk substrates Mnk
and Msk [13–15] (Figure 3c). Interestingly, the carboxy-
terminal half of both Mnk1 and Mnk2 is involved in Erk2
binding [14]. This suggests that the p42mpk1 interaction
motif that we have identified in Xenopus p90rsk may be a
relevant docking site in other Erk MAPKAP kinases. 
We have also found that mutation of the four most con-
served amino acids in 25Ct (LAQRR to ASQGA) impaired
p42mpk1 binding (Figure 3). A sequence of 16 amino acids
that is required for Erk1/2 binding and also contains the
motif LxxRR has been identified recently in the protein
tyrosine phosphatases PTP-SL and STEP [16]. In con-
trast, the 25Ct region shows no significant sequence simi-
larity with the motif R/KxxxxLxL, which is involved in
the binding of MAP kinases to nuclear substrates [4].
Thus, 25Ct may represent the first of a new class of MAP
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Figure 2
The MAP kinase docking site is required for
efficient phosphorylation and activation of
p90rsk. (a) Active p42mpk1 (200 ng) was
examined for its ability to phosphorylate
decreasing amounts (1 µg, 500 ng, 100 ng) of
either GST–D2, GST–D2∆43, GST–43Ct or
GST alone in an in vitro kinase assay. The
arrowheads indicate the positions of the
recombinant proteins. (b) Myc-tagged versions
of the indicated proteins were expressed in
Xenopus oocytes which then were either left
untreated (–), treated with progesterone for
12 h (+) or injected with recombinant Mos
protein (Mos) and incubated for 5 h. The
phosphorylation states of the Myc-tagged
proteins (upper panel), the endogenous p90rsk
(middle panel) and the endogenous p42mpk1
(lower panel) were analysed by mobility shifts
on immunoblots. The anti-p90rsk antibody does
not recognise p90rsk∆43. (c) Lysates prepared
from eight oocytes expressing either p90rsk or
p90rsk∆43 and either left untreated or treated
with progesterone were immunoprecipitated
with anti-Myc antibody and the activity of the
Myc-tagged p90rsk proteins was measured in
an in vitro kinase assay as described [17]. The
upper panel shows the autophosphorylation
activity of p90rsk (Auto-P) and the middle and
lower panels the activity of the Myc-tagged
p90rsk proteins on the exogenous substrates
S6 (S6-P; 2 µg) and GST–Myt1 (Myt1-P;
0.5 µg), respectively. (d) GST–43Ct inhibits
phosphorylation of p90rsk by p42mpk1 in vitro.
Active p42mpk1 was preincubated with 4 µg of
either GST–43Ct or GST alone and then
incubated with 35S-labelled p90rsk prepared in
rabbit reticulocyte lysate. 
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kinase docking site, which is present on cytoplasmic
targets of Erks and allows the preassembly of complexes
between MAP kinases and substrates before MAP kinase
activation. This association would ensure the preferential
phosphorylation of the associated substrate, especially for
those cases in which partial or transient levels of active
MAP kinase are produced, and it may be of particular
importance when the targets themselves are protein
kinases with the potential for further signal amplification. 
Supplementary material
Additional methodological details and three figures showing interaction
between D2 and p42mpk1 but not p38mpk2, specific phosphorylation of
D2 by p42mpk1 and the requirement for 43Ct for efficient D2 phospho-
rylation in vitro are published with this paper on the internet.
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Figure 3
The carboxy-terminal 25 amino acids of p90rsk are sufficient for
p42mpk1 binding and mutation of four amino acids in this sequence
impairs p42mpk1 binding. (a) Interaction in the yeast two-hybrid system
between p42mpk1 and the indicated proteins was determined as in
Figure 1. GST–43Ct(ASxGA) represents GST–43Ct with the
sequence LAQRR mutated to ASQGA (in the single-letter amino-acid
code). (b) Lysates were prepared from oocytes expressing Myc-
tagged p42mpk1 and used for pull-downs with either GST, GST–25Ct,
GST–43Ct or GST–43Ct(ASxGA). The total lysate and the pull-down
assays were analysed by immunoblotting with anti-p42mpk1 antibodies.
(c) Comparison of the carboxy-terminal amino-acid sequences in
protein kinases activated by Erk MAP kinases: Xenopus p90rskα,
mouse Rsk1and Rsk2, human Rsk3, chicken p90 S6 kinase II,
Drosophila p90 S6 kinase II, human Msk1, mouse Msk2 and mouse
Mnk1 and Mnk2. Amino-acid numbers of the amino-terminal and
carboxy-terminal residues are indicated. The consensus shows the
amino acids that are conserved in at least 8 out of the 10 sequences.
The asterisks indicate the four amino acids that are conserved in all of
the sequences and are required for p90rsk binding to p42mpk1.
(c)
** **
Xp90rskα 709  TPLLQPIKSSILAQRRVKKLP-STTL 733
mRsk1 700 TPQLKPIESSILAQRRVRKLP-STTL 724
mRsk2 715 SPVLEPVGRSTLAQRRGIKKITSTAL 740
hRsk3 708 APRLEPVLSSNLAQRRGMKRLTSTRL 733
chp90rsk 728  SPQLKPIESSILAQRRVKKLP-STTL 752
Dp90rsk 886  AANVGPVELSMLAKRRA-KDRANLHS 910
hMsk1 729 GFCLQNVDKAPLAKRRKMKKTSTSTE 754
mMsk2 718  GFFLKSVENAPLAKRRKQKLRSA   740
mMnk1 380  SMKLSPPSKSRLARRRALAQAGRSRD 405
mMnk2 380  CLQLSPPSQSKLAQRRQRASLSATPV 405
Consensus
 
LxPxxxSxLAxRRxxK
Lys
ate
GS
T
GS
T–
25
Ct
GS
T–
43
Ct
Anti-p42mpk1
blot
Current Biology   
 
(b)
(a)
309 –
309 733
715
733
733
733
691
691
709
690
+
+
–309
D2∆18
D2
D2∆43
25Ct
43Ct
43Ct(ASxGA)
Growth after mating
(+p42mpk1)
            25 aa
+
–
Lys
ate
GS
T
GS
T–
43
Ct
(A
Sx
GA
)
GS
T–
43
Ct
Endogenous
Myc-tagged
A MAP kinase docking site is required for phosphorylation and
activation of p90rsk/MAPKAP kinase-1
Anne-Claude Gavin and Angel R. Nebreda
Current Biology 1 March 1999, 9:281–284
S1
Supplementary materials and methods
Cloning, mutagenesis and expression of Myc-tagged proteins
in Xenopus oocytes
The cloning of Xenopus p90rsk and the truncated D1 and D2 domains
[S1] and of Xenopus p42mpk1 and p38mpk2 [S2] has been described. A
rabbit MAPKAP kinase-2 cDNA was provided by P. Cohen (MRC,
Dundee). The p90rsk∆43 and D2∆18 deletion mutants were prepared
by the introduction of stop codons following amino acid 690 and 715,
respectively, using the QuikChange mutagenesis kit (Stratagene). DNA
fragments containing either the last 43 or the last 25 amino acids of
p90rsk were obtained by PCR. All constructs were verified by DNA
sequencing. Complete details of the oligonucleotides and PCR condi-
tions will be provided upon request. All mRNAs were prepared from lin-
earized FTX5 expression constructs [S1] using the MEGAscript in vitro
transcription kit (Ambion). 
Immunoblotting, immunoprecipitation, GST pull-downs and in
vitro kinase assays
Oocyte microinjection and lysis, SDS–PAGE, immunoblotting with anti-
Myc, anti-p90rsk and anti-p42mpk1 antibodies and the in vitro kinase
assay with Myc-tagged p90rsk were performed as described [S1]. For
co-immunoprecipitation experiments, oocytes were lysed in 1 µl H1
kinase buffer per oocyte [S1] and clarified by two sequential centrifu-
gation steps at 14,000 rpm (Eppendorf) for 90 sec and 10 min,
respectively. GST pull-down assays were performed as described [S1]
using 4 µg of GST fusion proteins pre-bound to glutathione beads
(20 µl) which were mixed with lysates prepared from 10 oocytes. After
2 h at 4°C, the beads were washed three times and analysed by
immunoblotting. For the in vitro phosphorylation, GST fusion proteins
were incubated for 20 min at 30°C with active maltose-binding protein
(MalE)—p42mpk1 or MalE—p38mpk1 in 50 mM Tris pH 7.5, 2 µM micro-
cystin, 10 mM MgCl2, 10 µM ATP, 2 mM DTT, 2 µCi [γ-32P]ATP
(3000 Ci/mmol). MalE–p42mpk1 and MalE–p38mpk2 were activated by
in vitro phosphorylation with recombinant MKK1 and MKK6, respec-
tively. The 35S-labelled p90rsk was prepared in rabbit reticulocyte lysate
and then incubated with active MalE–p42mpk1 at 30°C in the above
kinase buffer but without [γ-32P]ATP.
Supplementary material
Figure S2
The D2 domain of p90rsk interacts with and is phosphorylated by
p42mpk1 but not p38mpk2. (a) Interaction in the yeast two-hybrid
system of p42mpk1 and p38mpk2 with full-length p90rsk, the D1 or D2
domains alone or MAPKAP kinase-2. Growth on selective media after
mating is shown. All mating mixtures grew at the same rate on non-
selective media. We observed the same results using as a bait either
the wild-type p42mpk1, a kinase-inactive mutant (K56R), mutants with
changes in the phosphorylation sites (TEY to either AEF or EEY, in
the single-letter amino-acid code), or a mutant with the activation 
loop sequence DHTGFLTEY replaced by GATL. (b) In vitro
phosphorylation of GST–D1 and GST–D2 (1 µg) by the same 
activity (normalised using myelin basic protein (MBP) as a substrate)
of p42mpk1 (100 ng) and p38mpk2 (200 ng). After electrophoresis 
and Coomassie blue staining, the radioactive bands were detected 
by autoradiography.
– p4
2m
pk
1
p3
8m
pk
2
p4
2m
pk
1
–
Coomassie
blue
32P labelling
(b)
p3
8m
pk
2
66 kDa
Current Biology   
66 kDa
GST–D1 GST–D2
MAPKAPK-2
MAPKAPK-2
D2 D1
p90rsk
p90rsk
D2 D1
p42mpk1
p38mpk2
(a)
Figure S1
The D2 domain of p90rsk interacts with p42mpk1. (a) Schematic
representation of full-length p90rsk and the two p90rsk kinase 
domain constructs D1 and D2. The three phosphorylation sites at
Thr360, Ser364 and Thr574 are indicated by asterisks. (b) Lysates
prepared from 10 oocytes expressing Myc-tagged p42mpk1 and 
either left untreated (control) or treated with progesterone were used
in pull-down assays with 4 µg of either GST, GST–D1 or GST–D2, 
as previously described [S1]; a ‘lysate only’ sample is also shown. 
The samples were analysed by immunoblotting with anti-Myc
antibodies (upper panel) and anti-phospho-p42mpk1 antibodies
(Promega; lower panel). The two arrowheads indicate the positions of
the Myc-tagged (upper) and the endogenous (lower) forms of
phosphorylated p42mpk1.
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Yeast transformation and mating
The GAL4 DNA-binding domain constructs were prepared in vector
pAS2-1 and the GAL4 activation domain constructs in vector pACT2
(Clontech). Transformation, mating and plating on both selective (His–)
and non-selective media were performed as described [S1].
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S2 Supplementary material
Figure S3
The 43Ct docking site is required for
phosphorylation of the D2 domain of p90rsk by
p42mpk1 in vitro. Decreasing amounts of active
p42mpk1 (400 ng, 200 ng and 100 ng) were
used to phosphorylate 1 µg of either GST–D2
or GST–D2∆43 for the indicated times. After
SDS–PAGE, the gels were stained with
Coomassie blue and the radioactive bands
detected by autoradiography.
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